Thus far, approximately 40 companies worldwide, including Codiak Biosciences, Evox Therapeutics, Tavec Pharmaceuticals, Carmine Therapeutics, Anjarium, and Micromedmark Biotech, have developed exosome-based therapies, which are expected to provide cost-effective and more accurate targeted therapies in the clinic ( However, challenges, such as large-scale production, purity, and batch homogeneity of exosomes, still limit their clinical application
Copper Peptides for Skin
Int J Oncol (2007) 30:76574
The nuclear basket mediates perinuclear mRNA scanning in budding yeast
Pathogens 11 , 84 (2022)
NAD+ vitamin therapy is generally safe for healthy adults